Meridian Bioscience, Inc. Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2013 Guidance
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
•reported fiscal 2013 third quarter and nine months net sales of $47.1 million and $139.7 million, respectively, increases of 12% and 8%, respectively, from the same periods of the prior fiscal year;
•reported third quarter operating income of $15.7 million, an increase of 24% over the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:
•reported fiscal 2013 third quarter and nine months net sales of $47.1 million and $139.7 million, respectively, increases of 12% and 8%, respectively, from the same periods of the prior fiscal year;
•reported third quarter operating income of $15.7 million, an increase of 24% over the same period of the prior fiscal year;
Help employers find you! Check out all the jobs and post your resume.